Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23042056
Abstract: Obesity is a risk factor that leads to the development of other diseases such as dyslipidemia and diabetes. These three metabolic disorders can occur simultaneously, hence, the treatment requires many drugs. Antioxidant compounds have been…
read more here.
Keywords:
molecular signaling;
dyslipidemia diabetes;
obesity dyslipidemia;
antioxidant compounds ... See more keywords